Guidance on strain changes in authorised COVID-19 vaccines
According to new guidance from ACCESS Consortium, a coalition of regulatory authorities from UK, Australia, Canada, Singapore & Switzerland, authorised COVID-19 vaccines modified in response to new variants will not need a brand new approval or “lengthy” clinical studies.
Source:
Medicines and Healthcare products Regulatory Agency